Wells Fargo turns bullish on this biotech company

Neurocrine Biosciences' drug portfolio is turning a corner, and the company will soon be “knocking on the doors of the…

Wells Fargo says consent order linked to 2016 scandal lifted

Wells Fargo Chairman and CEO Charlie Scharf attends The Future of Everything presented by The Wall Street Journal at Spring…

Goldman Sachs (GS) Earnings Q4 2023

Goldman Sachs on Tuesday it reported fourth-quarter results that beat analysts' expectations for better-than-expected wealth and asset management revenue. Here's…